Epoxymicheliolide is primarily researched for its potential therapeutic applications in the field of medicine, particularly in cancer treatment. Studies have shown that it exhibits significant anti-cancer properties by inducing apoptosis (programmed cell death) in various cancer cell lines. Its mechanism involves the inhibition of key signaling pathways that promote tumor growth and survival, making it a promising candidate for developing novel anti-cancer drugs. Additionally, epoxymicheliolide has been explored for its anti-inflammatory effects, which could be beneficial in treating inflammatory diseases and conditions. Preliminary research also indicates potential neuroprotective properties, which may be useful in treating neurological disorders in the future. Research is ongoing to further understand its pharmacological potential and optimize its efficacy for clinical use.